FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090612 [Registered on: 09/07/2025] Trial Registered Prospectively
Last Modified On: 25/06/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of Jambwadi Kashaya over Vasadi Kashaya in Raktapradara (Dysfunctional Uterine Bleeding)  
Scientific Title of Study   A Controlled Comparative Clinical Trial to Evaluate the Efficacy of Jambwadi Kashaya over Vasadi Kashaya in the Management of Raktapradara(Dysfunctional Uterine Bleeding) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Soumya Benachanamardi 
Designation  PG Scholar 
Affiliation  SDMTs Ayurvedic College and Hospital Terdal 
Address  SDM TRUSTS AYURVEDIC MEDICAL COLLEGE DANIGOND POST GRADUATE CENTRE AND PADMA AYURVEDIC HOSPITAL AND RESEARCH CENTRE DR SHIDDHANT NAGAR TERDAL 587315 BAGALKOT KARNATAKA

Bagalkot
KARNATAKA
587315
India 
Phone  7483751466  
Fax    
Email  soumya281099@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Parashuram K Rawal 
Designation  PROFESSOR AND HOD 
Affiliation  SDMTs ayurvedic college and hospital terdal 
Address  SDM TRUSTS AYURVEDIC MEDICAL COLLEGE DANIGOND POST GRADUATE CENTRE AND PADMA AYURVEDIC HOSPITAL AND RESEARCH CENTRE DR SHIDDHANT NAGAR TERDAL 587315 BAGALKOT KARNATAKA

Bagalkot
KARNATAKA
587315
India 
Phone  9880976151  
Fax    
Email  Chaitanya.rawal5@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Soumya Benachanamardi 
Designation  PG Scholar 
Affiliation  SDMTs ayurvedic college and hospital terdal 
Address  SDM TRUSTS AYURVEDIC MEDICAL COLLEGE DANIGOND POST GRADUATE CENTRE AND PADMA AYURVEDIC HOSPITAL AND RESEARCH CENTRE DR SHIDDHANT NAGAR TERDAL 587315 BAGALKOT KARNATAKA

Bagalkot
KARNATAKA
587315
India 
Phone  7483751466  
Fax    
Email  soumya281099@gmail.com  
 
Source of Monetary or Material Support  
SDM Trusts Ayurvedic Medical College Post Graduation Centre and Padma Hospital Terdal 587315 Bagalkot Karnataka India  
 
Primary Sponsor  
Name  Dr Soumya Benachanamardi 
Address  SDM TRUSTS AYURVEDIC MEDICAL COLLEGE DANIGOND POST GRADUATE CENTRE AND PADMA AYURVEDIC HOSPITAL AND RESEARCH CENTRE DR SHIDDHANT NAGAR TERDAL 587315 BAGALKOT KARNATAKA.  
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Soumya Benachanamardi  SDMTs Ayurvedic College and Hospital Terdal  SDM TRUSTS AYURVEDIC MEDICAL COLLEGE DANIGOND POST GRADUATE CENTRE AND PADMA AYURVEDIC HOSPITAL AND RESEARCH CENTRE DR SHIDDHANT NAGAR TERDAL 587315 BAGALKOT KARNATAKA
Bagalkot
KARNATAKA 
07483751466

soumya281099@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SDMTAMC Institutional ethical committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N920||Excessive and frequent menstruation with regular cycle. Ayurveda Condition: ASRUGDARAH/RAKTAPRADARAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Vasadi Kashaya, Reference: Sahasrayoga , Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 50(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 5 Days, anupAna/sahapAna: Yes(details: Sita and Ghruta), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Jambwadi Kashaya, Reference: Sushruta Samhita, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 50(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 5 Days, anupAna/sahapAna: Yes(details: Sita and Ghruta), Additional Information: -
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  1.Patients of age group 16 - 40 years
2.Patients with excessive and prolonged bleeding p/v during menstruation
3.Patient willing to sign Consent form  
 
ExclusionCriteria 
Details  1.Hb% below 8gms
2.Patient using Intra uterine contraceptive devices
3.Known cases of Hypertension, Diabetes mellitus, Malignancy, Tuberculosis or any uncontrolled severe systematic disorders and metabolic disorders
4.Known cases of Coagulation disorders
5.Known cases of any pelvic pathology (e.g.Uterine fibroid, Pelvic inflammatory disease)
6.Any other illness reseacher feels that interfere the inyervention of the study 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Effect of Trial drug on improvement of classical symptoms of Raktapradara (Dysfunctional Uterine Bleeding)   5 Days - Starting fron 5th day of menstruation for 5 days X 2 consecutive cycles
Follow up - 10th of Menstruation 
 
Secondary Outcome  
Outcome  TimePoints 
Safety of the Trial drug and adverse drug reaction and aggravation in symptoms of Raktapradara(Dysfunctional Uterine Bleeding)  5 Days - Starting fron 5th day of menstruation for 5 days X 2 consecutive cycles
Follow up - 10th of Menstruation 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   16/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Raktapradara has been mentioned one among Rakta pradoshaja vikara. It is mentioned in ayurveda that vitiated vata withholding rakta increases in their amount and reaches rajavaha srotas and increases raja. The excessive flow of raja from yoni is known as Raktapradara. Clinical features of Raktapradara includes atiarthava pravrutti, deergakala arthava pravrutti associated with savedana arthava pravrutti and anga marda.
Raktapradara can be corelated with Dysfunctional Uterine Bleeding explained in modern science. DUB is a state of abnormal uterine bleeding without any clinically detectable organic, systemic and iatrogenic cause(PID, Pregnancy etc excluded).
Objectives of the study is to evaluate the effect of Jambwadi Kashaya in the management of Raktapradara (DUB). This is the randomized comparative clinical study. Total 40 patients of Raktapradara are selected and randomly devided into 2 groups. Group A given Jambwadi Kashaya and Group B given Vasadi Kashaya. The subjective and objective parameters are selected for assessment. Total study duration is 3 Menstrual Cycles  and includes 3 visits. After study data will be collected from case report form and statistically analysed by using appropriate parametric and non parametric tests and result will be obtained. On the basis of result conclusion will be drawn.
 
Close